-
Loading metrics
Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates
- Daniel Y. Zhu ,
- Matthew J. Gorman ,
-
Dansu Yuan,
Roles Investigation
Affiliation Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America
⨯ -
Jingyou Yu,
Roles Investigation
Affiliation Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America
⨯ - Noe B. Mercado,
- Katherine McMahan,
- Erica N. Borducchi,
- Michelle Lifton,
- Jinyan Liu,
- Felix Nampanya,
- Shivani Patel,
- Lauren Peter,
-
Lisa H. Tostanoski,
Roles Investigation
Affiliation Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America
⨯ - Laurent Pessaint,
- Alex Van Ry,
- Brad Finneyfrock,
- Jason Velasco,
- Elyse Teow,
- Renita Brown,
- Anthony Cook,
- Hanne Andersen,
- Mark G. Lewis,
- Douglas A. Lauffenburger,
- Dan H. Barouch,
- [ ... ],
-
Galit Alter
Roles Conceptualization, Supervision, Visualization, Writing – original draft, Writing – review & editing
* E-mail: galter@mgh.harvard.edu
Affiliation Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America
⨯ - [ view all ]
- [ view less ]
https://orcid.org/0000-0003-4815-7237
Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates
- Daniel Y. Zhu,
- Matthew J. Gorman,
- Dansu Yuan,
- Jingyou Yu,
- Noe B. Mercado,
- Katherine McMahan,
- Erica N. Borducchi,
- Michelle Lifton,
- Jinyan Liu,
- Felix Nampanya
- Published: May 5, 2022
- https://doi.org/10.1371/journal.pbio.3001609